Get all your news in one place.

100’s of premium titles.
One app.

Get all your news in one place.

100’s of premium titles. One news app.

The Latest Breaking News from AbbVie

This Is What Whales Are Betting On AbbVie

A whale with a lot of money to spend has taken a noticeably bearish stance on AbbVie. Looking at options history for AbbVie (NYSE:ABBV) we detected 19 strange trades.

Benzinga

$1000 Invested In This Stock 5 Years Ago, Would Be Worth This Much

AbbVie (NYSE:ABBV) has outperformed the market over the past 5 years by 2.43% on an annualized basis.

Benzinga

3 Buy-Rated Stocks Yielding More than 4%

As the stock market is expected to remain volatile owing to the anticipated interest rate hikes to control inflation, it could be wise to bet on fundamentally strong dividend-yielding stocks AbbVie (ABBV), Philip Morris (PM), and Vector Group (VGR) for securing a steady income stream. These stocks are rated ‘Buy’…

StockNews.com

From analysis to the latest developments in health,
read the most diverse news in one place.

FDA Approves AbbVie's Upadacitinib For Refractory Atopic Dermatitis In Patients 12 Years & Older

The

Benzinga

The Kiplinger Dividend 15: Our Favorite Dividend-Paying Stocks

The Kiplinger Dividend 15 are poised to benefit as falling interest rates lure investors back to dividend-paying stocks.

Kiplinger

1 … 9 10 11 12

People

Jay Hatfield

43 stories

From analysis to the latest developments in health,
read the most diverse news in one place.

Organisations

Air Products Chemicals

22 stories

Read news from The Economist, FT, and more,
with one subscription

Topics

Interest Rates

5,754 stories

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.